These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 31676755)
1. Author Correction: Targeted NUDT5 inhibitors block hormone signaling in breast cancer cells. Page BDG; Valerie NCK; Wright RHG; Wallner O; Isaksson R; Carter M; Rudd SG; Loseva O; Jemth AS; Almlöf I; Font-Mateu J; Llona-Minguez S; Baranczewski P; Jeppsson F; Homan E; Almqvist H; Axelsson H; Regmi S; Gustavsson AL; Lundbäck T; Scobie M; Strömberg K; Stenmark P; Beato M; Helleday T Nat Commun; 2019 Nov; 10(1):5050. PubMed ID: 31676755 [TBL] [Abstract][Full Text] [Related]
2. Targeted NUDT5 inhibitors block hormone signaling in breast cancer cells. Page BDG; Valerie NCK; Wright RHG; Wallner O; Isaksson R; Carter M; Rudd SG; Loseva O; Jemth AS; Almlöf I; Font-Mateu J; Llona-Minguez S; Baranczewski P; Jeppsson F; Homan E; Almqvist H; Axelsson H; Regmi S; Gustavsson AL; Lundbäck T; Scobie M; Strömberg K; Stenmark P; Beato M; Helleday T Nat Commun; 2018 Jan; 9(1):250. PubMed ID: 29343827 [TBL] [Abstract][Full Text] [Related]
3. Author Correction: Temporal dynamic reorganization of 3D chromatin architecture in hormone-induced breast cancer and endocrine resistance. Zhou Y; Gerrard DL; Wang J; Li T; Yang Y; Fritz AJ; Rajendran M; Fu X; Stein G; Schiff R; Lin S; Frietze S; Jin VX Nat Commun; 2020 Apr; 11(1):1967. PubMed ID: 32313124 [TBL] [Abstract][Full Text] [Related]
4. Author Correction: LSD1 activation promotes inducible EMT programs and modulates the tumour microenvironment in breast cancer. Boulding T; McCuaig RD; Tan A; Hardy K; Wu F; Dunn J; Kalimutho M; Sutton CR; Forwood JK; Bert AG; Goodall GJ; Malik L; Yip D; Dahlstrom JE; Zafar A; Khanna KK; Rao S Sci Rep; 2019 Dec; 9(1):18771. PubMed ID: 31801957 [TBL] [Abstract][Full Text] [Related]
5. Author Correction: Different signatures of miR-16, miR-30b and miR-93 in exosomes from breast cancer and DCIS patients. Ni Q; Stevic I; Pan C; Müller V; Oliveira-Ferrer L; Pantel K; Schwarzenbach H Sci Rep; 2019 Dec; 9(1):18700. PubMed ID: 31804497 [TBL] [Abstract][Full Text] [Related]
6. Author Correction: Co-delivery of docetaxel and silibinin using pH-sensitive micelles improves therapy of metastatic breast cancer. Dong XY; Lang TQ; Yin Q; Zhang PC; Li YP Acta Pharmacol Sin; 2019 Sep; 40(9):1258. PubMed ID: 31350459 [TBL] [Abstract][Full Text] [Related]
7. Author Correction: Validating a breast cancer score in Spanish women. The MCC-Spain study. Dierssen-Sotos T; Gómez-Acebo I; Palazuelos C; Fernández-Navarro P; Altzibar JM; González-Donquiles C; Ardanaz E; Bustamante M; Alonso-Molero J; Vidal C; Bayo-Calero J; Tardón A; Salas D; Marcos-Gragera R; Moreno V; Rodriguez-Cundin P; Castaño-Vinyals G; Ederra M; Vilorio-Marqués L; Amiano P; Pérez-Gómez B; Aragonés N; Kogevinas M; Pollán M; Llorca J Sci Rep; 2020 Apr; 10(1):5980. PubMed ID: 32238823 [TBL] [Abstract][Full Text] [Related]
8. Author Correction: Quantitative proteomic analysis of enhanced cellular effects of electrochemotherapy with Cisplatin in triple-negative breast cancer cells. Mittal L; Aryal UK; Camarillo IG; Ferreira RM; Sundararajan R Sci Rep; 2019 Dec; 9(1):19124. PubMed ID: 31819154 [TBL] [Abstract][Full Text] [Related]
9. Author Correction: SREBP1 drives keratin-80-dependent cytoskeletal changes and invasive behavior in endocrine-resistant ERα breast cancer. Perone Y; Farrugia AJ; Rodríguez-Meira A; Győrffy B; Ion C; Uggetti A; Chronopoulos A; Marrazzo P; Faronato M; Shousha S; Davies C; Steel JH; Patel N; Del Rio Hernandez A; Coombes C; Pruneri G; Lim A; Calvo F; Magnani L Nat Commun; 2019 Aug; 10(1):3791. PubMed ID: 31427580 [TBL] [Abstract][Full Text] [Related]
10. Author Correction: Drug-induced PD-L1 expression and cell stress response in breast cancer cells can be balanced by drug combination. Gilad Y; Eliaz Y; Yu Y; Han SJ; O'Malley BW; Lonard DM Sci Rep; 2020 Mar; 10(1):4463. PubMed ID: 32132607 [TBL] [Abstract][Full Text] [Related]
11. Author Correction: PyMT-1099, a versatile murine cell model for EMT in breast cancer. Saxena M; Kalathur RKR; Neutzner M; Christofori G Sci Rep; 2020 Jul; 10(1):11444. PubMed ID: 32632219 [TBL] [Abstract][Full Text] [Related]
12. Author Correction: Interleukin-6/STAT3 signalling regulates adipocyte induced epithelial-mesenchymal transition in breast cancer cells. Gyamfi J; Lee YH; Eom M; Choi J Sci Rep; 2020 Jul; 10(1):13049. PubMed ID: 32724090 [TBL] [Abstract][Full Text] [Related]
14. Author Correction: Genomic Prediction of 16 Complex Disease Risks Including Heart Attack, Diabetes, Breast and Prostate Cancer. Lello L; Raben TG; Yong SY; Tellier LCAM; Hsu SDH Sci Rep; 2019 Nov; 9(1):17515. PubMed ID: 31748697 [TBL] [Abstract][Full Text] [Related]
15. Author Correction: A new microdispersed albumin derivative potentially useful for radio-guided surgery of occult breast cancer lesions. Caviglioli G; Chinol M; Baldassari S; Garaboldi L; Zuccari G; Petretto A; Drava G; Sinico C; Paganelli G Sci Rep; 2020 Mar; 10(1):4633. PubMed ID: 32157105 [TBL] [Abstract][Full Text] [Related]
17. Author Correction: G9a regulates breast cancer growth by modulating iron homeostasis through the repression of ferroxidase hephaestin. Wang YF; Zhang J; Su Y; Shen YY; Jiang DX; Hou YY; Geng MY; Ding J; Chen Y Nat Commun; 2020 Jul; 11(1):3789. PubMed ID: 32709895 [TBL] [Abstract][Full Text] [Related]
18. Author Correction: Dysregulated JAK2 expression by TrkC promotes metastasis potential, and EMT program of metastatic breast cancer. Kim MS; Jeong J; Seo J; Kim HS; Kim SJ; Jin W Sci Rep; 2020 Jul; 10(1):11103. PubMed ID: 32632170 [TBL] [Abstract][Full Text] [Related]
20. Author Correction: Neutrophil to lymphocyte ratio and breast cancer risk: analysis by subtype and potential interactions. Gago-Dominguez M; Matabuena M; Redondo CM; Patel SP; Carracedo A; Ponte SM; Martínez ME; Castelao JE Sci Rep; 2020 Nov; 10(1):20641. PubMed ID: 33219311 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]